Terrence C. DAHL,Munir A. HUSSAIN,Robert A. LIPPER,Robert L. JERZEWSKI,Mark M. MENNING,Reza OLIYAI,Taiyin YANG
申请号：
US15370588
公开号：
US20170079999A1
申请日:
2016.12.06
申请国别(地区):
US
年份:
2017
代理人:
摘要：
In accordance with this invention a novel pharmaceutical product containing efavirenz, emtricitabine and tenofovir DF are provided as a multicomponent unitary oral dosage form, component 1 comprising tenofovir DF (and, optionally, emtricitabine) and component 2 comprising efavirenz, wherein components 1 and 2 are in a stabilizing configuration. In preferred embodiments component 1 is made by dry granulation.
